Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 23, 2023

BUY
$314.42 - $351.91 $38,044 - $42,581
121 New
121 $42,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $285 - $321
-1 Reduced 3.03%
32 $9,000
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $25,740 - $28,719
-94 Reduced 74.02%
33 $10,000
Q2 2021

Aug 20, 2021

BUY
$187.49 - $221.1 $23,811 - $28,079
127 New
127 $26,000
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $1,797 - $2,230
-9 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $1,500 - $2,015
9 New
9 $2,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Stonebridge Capital Advisors LLC Portfolio

Follow Stonebridge Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.